Delivery Order SPE2DB22D1103-SPE2DB25FTNF2
Award Date
5/23/25
Potential Completion Date
5/27/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,727.79 firm-fixed-price delivery order supports the procurement of CRESTOR 40 MG TABLET 30S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., which enables the efficient...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Crestor 10 mg tablets, a medication used to treat high cholesterol. The contract has a firm fixed price of $6,779.64 and a period of performance through April 30, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,194.68 firm fixed-price delivery order is for the supply of CRESTOR 10 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of March 28, 2025 and was awarded on March 27, 2025 with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB20D1051|SPE2DB24FD7PG) with a firm fixed price of $1,386.66 for the supply of CRESTOR 20 MG TABLET 90S to the Defense Logistics Agency (DLA) Troop Support Medical. The award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award, which is part of a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,132.69 firm fixed-price delivery order is for the provision of Crestor 20 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the...
This federal contract award, valued at $2,304.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Crestor 20 mg tablets, a cardiovascular medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as a primary vehicle for...
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM42E, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,485.50 delivery order contract is for the supply of 4,563,458,779 units of Rosuvastatin Calcium 40 mg tablets, with a completion date of January 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $34,256.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 40 mg tablets in 500-count bottles. This is a firm-fixed-price delivery order with a completion date of September 26, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,268.53 firm fixed-price delivery order is for the supply of 500 units of Rosuvastatin Calcium 5 mg tablets. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $19,800.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4,563,597,742 tablets of Rosuvastatin Calcium 10 mg. The delivery order has a period of performance through February 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, provides a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of...